TNFRSF4 and influenza: The influenza strains used in the 2018 vaccine formulation, which we used here as the antigen in the OX40 AIM assay and proliferation assay, were not circulating during the 1990s, although considerable cross-reactivity with variable and conserved epitopes against 1990s strains may be expected (52).